SEC Form 4 · accession 0001179110-17-005668
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles B Haaser
Officer — VP Fin & Chief Accting Officer
Period of report
Apr 1, 2017
Accepted (ET)
Apr 4, 2017 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2017 | F | 2,673 | $0.37 | D | 27,892 | D | |
| Common StockF2 | holding | — | — | — | 21,284 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15.
- F2Shares acquired as Company matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.